Zeus Capital advises Kind Consumer in relation to Fundraising
04 Dec 2015
Zeus Capital acted for Kind Consumer in relation to its recent private fundraising which, following the introduction of Woodford Investment Management by Zeus Capital, resulted in Woodford Investment Management making an investment of £20 million in the company.
Kind Consumer has developed the UK’s first medically approved nicotine inhaler with the shape and feel of a cigarette. The product, named Voke, will address the nicotine replacement therapy market as the only medically approved smoking cessation device available. Voke is expected to be launched in the UK towards the end of this year.
<blockquote><em>We are delighted to have been involved in Kind Consumer’s recent fundraising which is an important milestone for an extremely exciting company. With the only medically approved product in what is an exciting market and with the support of a world class strategic investor, we are extremely excited about the future prospects for Kind Consumer and the up-coming launch of Voke.</em>
<strong><em>Dominic Wilson</em></strong><em>, Head of Healthcare Sales at Zeus Capital</em></blockquote>